Abstract: A gas laser tube assembly is disclosed wherein an elongated gas laser plasma tube is connected by a releasable connection to a member having a gas port positioned adjacent one end of the elongated gas laser plasma tube in spaced relationship thereto along the longitudinal axis of the plasma tube. The releasable connection and the member are arranged for telescoping movement with respect to another in either direction along the longitudinal axis of the plasma tube at least upon release of the connection thereby facilitating removal and installation of the plasma tube from the assembly. The releasable connection includes a first part connected to one end of the plasma tube and a second part releasably connected to the member with the first and second parts being releasably connected to one another.

Abstract: A composition for treating an iron deficiency disease, composed of (1) an amount, effective for treating said disease, of a compound having a hydrotalcite-like crystal structure and represented by the following formula(Fe.sup.2+,Mg.sup.2+).sub.x (Al.sup.3+,Fe.sup.3+).sub.2 (OH).sub.2x+6-nz (A.sup.n-).sub.z.mH.sub.2 Owherein A.sup.n- represents an anion having a valence of n, Mg.sup.2+ is within the range of O.ltoreq.Mg.sup.2+ <x, Fe.sup.3+ is within the range of O.ltoreq.Fe.sup.3+ 2, x is a number represented by 1.ltoreq..times.<20, z is a number represented by 0<z<3, and m is a number represented by O.ltoreq.m<8, and (2) a pharmaceutically acceptable diluent or carrier, and a method for treating an iron deficiency disease, which comprises orally administering an amount, effective for treating said disease, of the compound represented by the aforesaid formula.